Iaconangelo CJ, Serrano D, Adams AM, Trugman JM, et al. Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials. Headache 2023;63:1412-1422.
PMID: 37873925